Search research articles
Contact Us
Filters
Showing results (501-510 of 518) with videos related to
Page
of 52
Sort By:
Journal for Immunotherapy of Cancer
|
October 2, 2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Marc Oliva, Douglas Chepeha, Daniel V Araujo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Jonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Annals of Surgery
|
October 26, 2017
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh, Jorg Kleeff, Christopher M Halloran, et al.
Cell Death & Disease
|
April 24, 2026
βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer
George Sharbeen, John Kokkinos, Grace Schulstad, et al.
JAMA Oncology
|
March 5, 2026
Genomic Therapy Matching in Rare and Refractory Cancers
Frank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
Nature Communications
|
February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Jonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Journal of the National Cancer Institute
|
December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial
William Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
BMJ Open
|
October 3, 2019
The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers
Ashika D Maharaj, Jennifer F Holland, Ri O Scarborough, et al.
The Lancet. Oncology
|
March 7, 2018
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
Emil Ter Veer, L Bengt van Rijssen, Marc G Besselink, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 518) with videos related to
Sort By:
Page
of 52
Journal for Immunotherapy of Cancer
|
October 2, 2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Marc Oliva, Douglas Chepeha, Daniel V Araujo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Jonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Annals of Surgery
|
October 26, 2017
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh, Jorg Kleeff, Christopher M Halloran, et al.
Cell Death & Disease
|
April 24, 2026
βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer
George Sharbeen, John Kokkinos, Grace Schulstad, et al.
JAMA Oncology
|
March 5, 2026
Genomic Therapy Matching in Rare and Refractory Cancers
Frank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
Nature Communications
|
February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Jonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Journal of the National Cancer Institute
|
December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial
William Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
BMJ Open
|
October 3, 2019
The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers
Ashika D Maharaj, Jennifer F Holland, Ri O Scarborough, et al.
The Lancet. Oncology
|
March 7, 2018
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
Emil Ter Veer, L Bengt van Rijssen, Marc G Besselink, et al.
Page
of 52